Skip to main content
Signal8

Taylor Ben R

SEC insider (Form 3/4/5 filer). CIK 0001712276. Chief Financial Officer at RECURSION PHARMACEUTICALS, INC. (RXRX). 29 reported Form 4/5 transactions since Sep 2024; latest on Sep 15, 2026. Located in SALT LAKE CITY, UT.

Companies Taylor Ben R has filed insider reports for

  • RECURSION PHARMACEUTICALS, INC. (RXRX): Officer, Chief Financial Officer
Taylor Ben R profile photo

Taylor Ben R

CIK: 0001712276

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (10.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (17.2%)

Compensation grants

Other (G, F, J, C, D, …)21 (72.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RECURSION PHARMACEUTICALS, INC. logo
RXRX

RECURSION PHARMACEUTICALS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (29 total)

  • RECURSION PHARMACEUTICALS, INC. logo
    RXRX

    RECURSION PHARMACEUTICALS, INC.

    Sep 15, 2026
    Tax Payment
    Direct
    5.4K shares at avg. $3.41$18K
  • RECURSION PHARMACEUTICALS, INC. logo
    RXRX

    RECURSION PHARMACEUTICALS, INC.

    Aug 17, 2026
    Tax Payment
    Direct
    25K shares at avg. $3.16$79K
  • RECURSION PHARMACEUTICALS, INC. logo
    RXRX

    RECURSION PHARMACEUTICALS, INC.

    Jun 15, 2026
    Tax Payment
    Direct
    5.4K shares at avg. $3.15$17K
  • RECURSION PHARMACEUTICALS, INC. logo
    RXRX

    RECURSION PHARMACEUTICALS, INC.

    May 15, 2026
    Tax Payment
    Direct
    25K shares at avg. $3.04$76K
  • RECURSION PHARMACEUTICALS, INC. logo
    RXRX

    RECURSION PHARMACEUTICALS, INC.

    Apr 6, 2026
    Tax Payment
    Direct
    48K shares at avg. $3.11$149K
  • RECURSION PHARMACEUTICALS, INC. logo
    RXRX

    RECURSION PHARMACEUTICALS, INC.

    Mar 17, 2026
    Sale
    Direct
    8K shares at avg. $3.39$27K
  • RECURSION PHARMACEUTICALS, INC. logo
    RXRX

    RECURSION PHARMACEUTICALS, INC.

    Mar 16, 2026
    Tax Payment
    Direct
    7.1K shares at avg. $3.42$24K
  • RECURSION PHARMACEUTICALS, INC. logo
    RXRX

    RECURSION PHARMACEUTICALS, INC.

    Feb 18, 2026
    Sale
    Direct
    13.4K shares at avg. $3.08$41K
  • RECURSION PHARMACEUTICALS, INC. logo
    RXRX

    RECURSION PHARMACEUTICALS, INC.

    Feb 17, 2026
    Tax Payment
    Direct
    11.9K shares at avg. $3.49$42K
  • RECURSION PHARMACEUTICALS, INC. logo
    RXRX

    RECURSION PHARMACEUTICALS, INC.

    Feb 6, 2026
    Award
    Direct
    446.3K shares-

1-10 of 29